Si-Bone, Inc. (SIBN)
Nasdaq · Surgical & Medical Instruments & Apparatus · Manufacturing · CIK 1459839 · fiscal year ends in Dec
Closing price $22.43 on 29 Oct 2026; 52-week range $11.61 to $22.43.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $213.6M
- Revenue growth
- 15.3%
- Net income, last twelve months
- -$14.6M
- Earnings per share
- -$0.34
- Gross margin
- 79.5%
- Operating margin
- -8.3%
- Net margin
- -6.9%
- Free cash flow
- -$4.4M
- Return on equity
- -8.0%
- Market value
- $1.0B
- Dividend yield
- 0.0%
- Cash
- $33.1M
- Debt
- $35.6M
- Debt to equity
- 0.20
- Shares outstanding
- 44.7M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $200.9M | -$22.3M | -$18.9M | -$0.44 | -$9.1M | 10-K filed 24 Feb 2026 |
| FY2024 | 31 Dec 2024 | $167.2M | -$35.2M | -$30.9M | -$0.75 | -$22.9M | 10-K filed 25 Feb 2025 |
| FY2023 | 31 Dec 2023 | $138.9M | -$46.9M | -$43.3M | -$1.13 | -$26.5M | 10-K filed 27 Feb 2024 |
| FY2022 | 31 Dec 2022 | $106.4M | -$59.6M | -$61.3M | -$1.79 | -$51.2M | 10-K filed 2 Mar 2023 |
| FY2021 | 31 Dec 2021 | $90.2M | -$51.7M | -$56.6M | -$1.71 | -$45.9M | 10-K filed 1 Mar 2022 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $56.0M | -$4.1M | -$0.09 |
| Q1 FY2026 | 31 Mar 2026 | $52.6M | -$4.3M | -$0.10 |
| Q4 FY2025 | 31 Dec 2025 | $56.3M | -$1.6M | -$0.04 |
| Q3 FY2025 | 30 Sep 2025 | $48.7M | -$4.6M | -$0.11 |
| Q2 FY2025 | 30 Jun 2025 | $48.6M | -$6.2M | -$0.14 |
| Q1 FY2025 | 31 Mar 2025 | $47.3M | -$6.5M | -$0.15 |
| Q4 FY2024 | 31 Dec 2024 | $49.0M | -$4.5M | -$0.11 |
| Q3 FY2024 | 30 Sep 2024 | $40.3M | -$6.6M | -$0.16 |
Revenue by segment
As the company reports it in the segment note of its annual report.
By region, FY2025
| Segment | Revenue | Share |
|---|---|---|
| United States | $191.1M | 95.1% |
| International | $9.8M | 4.9% |
Company events
The newest 8-K filings of 68 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 11 Sep 2026 | 8-K | Material agreement, New debt, Other events | 1.01, 2.03, 8.01, 9.01 |
| 3 Aug 2026 | 8-K | Results | 2.02, 9.01 |
| 8 Jun 2026 | 8-K | Material agreement, New debt, Shareholder vote | 1.01, 2.03, 5.07, 9.01 |
| 11 May 2026 | 8-K | Results | 2.02, 9.01 |
| 23 Feb 2026 | 8-K | Results, Leadership change, Material agreement | 1.01, 2.02, 5.02 |
| 12 Jan 2026 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 10 Nov 2025 | 8-K | Results, Leadership change | 2.02, 5.02, 9.01 |
| 4 Aug 2025 | 8-K | Results, Leadership change | 2.02, 5.02, 9.01 |
| 6 Jun 2025 | 8-K | Shareholder vote | 5.07, 9.01 |
| 5 May 2025 | 8-K | Results | 2.02, 9.01 |
| 24 Feb 2025 | 8-K | Results | 2.02, 9.01 |
| 13 Jan 2025 | 8-K | Results | 2.02, 9.01 |
Every filing
The newest filings with the SEC of 177 held.
| Filed | Form | Period |
|---|---|---|
| 11 Sep 2026 | 8-K | 21 Aug 2026 |
| 4 Aug 2026 | 10-Q | 30 Jun 2026 |
| 3 Aug 2026 | 8-K | 3 Aug 2026 |
| 8 Jun 2026 | 8-K | 4 Jun 2026 |
| 11 May 2026 | 10-Q | 31 Mar 2026 |
| 11 May 2026 | 8-K | 11 May 2026 |
| 21 Apr 2026 | ARS | 31 Dec 2025 |
| 21 Apr 2026 | DEFA14A | – |
| 21 Apr 2026 | DEF 14A | 31 Dec 2025 |
| 24 Feb 2026 | S-8 | – |
| 24 Feb 2026 | S-3ASR | – |
| 24 Feb 2026 | 10-K | 31 Dec 2025 |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 12 Oct 2026 | Francis Laura, Chief Executive Officer | Sale under a trading plan | 38,006 | $20.05 | $762.0K | 379,256 | 14 Oct 2026 |
| 5 Oct 2026 | Maheshwari Anshul, Chief Op & Financial Officer | Sale under a trading plan | 1,731 | $19.50 | $33.8K | 218,235 | 6 Oct 2026 |
| 2 Oct 2026 | Pisetsky Michael A., SVP, Ops & Adm/Chief Legal Ofr | Sale outside a trading plan | 1,300 | $18.20 | $23.7K | 272,350 | 6 Oct 2026 |
| 2 Oct 2026 | Pisetsky Michael A., SVP, Ops & Adm/Chief Legal Ofr | Sale outside a trading plan | 1,799 | $18.14 | $32.6K | 270,551 | 6 Oct 2026 |
| 2 Oct 2026 | Pisetsky Michael A., SVP, Ops & Adm/Chief Legal Ofr | Sale outside a trading plan | 34 | $18.14 | $617 | 270,517 | 6 Oct 2026 |
| 2 Oct 2026 | Maheshwari Anshul, Chief Op & Financial Officer | Sale under a trading plan | 1,560 | $18.17 | $28.3K | 221,724 | 6 Oct 2026 |
| 2 Oct 2026 | Maheshwari Anshul, Chief Op & Financial Officer | Sale under a trading plan | 1,758 | $18.19 | $32.0K | 219,966 | 6 Oct 2026 |
| 1 Oct 2026 | Dunn Jeffrey W, Director | Sale outside a trading plan | 20,000 | $18.47 | $369.4K | 16,057 | 5 Oct 2026 |
| 1 Sep 2026 | Dunn Jeffrey W, Director | Sale under a trading plan | 18,633 | $18.91 | $352.3K | 17,424 | 3 Sep 2026 |
| 1 Sep 2026 | Dunn Jeffrey W, Director | Sale under a trading plan | 1,367 | $18.91 | $25.8K | 16,057 | 3 Sep 2026 |
| 24 Aug 2026 | Francis Laura, Chief Executive Officer | Sale under a trading plan | 25,972 | $20.12 | $522.6K | 291,491 | 26 Aug 2026 |
| 24 Aug 2026 | Maheshwari Anshul, Chief Op & Financial Officer | Sale under a trading plan | 11,636 | $20.11 | $234.0K | 223,284 | 26 Aug 2026 |
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| Filed | Seller | Shares | Value | Planned sale |
|---|---|---|---|---|
| 29 Oct 2026 | ANSHUL MAHESHWARI, Officer | 3,738 | $81.6K | 29 Oct 2026 |
| 29 Oct 2026 | MICHAEL PISETSKY SEPARATE PROPERTY TRUST, Officer | 29,665 | $647.6K | 29 Oct 2026 |
| 13 Oct 2026 | DAVID & LAURA FRANCIS JOINT REV TRU/A DTD 01/03/2003, Director, Officer | 38,006 | $736.2K | 12 Oct 2026 |
| 5 Oct 2026 | ANSHUL MAHESHWARI, Officer | 1,731 | $31.3K | 5 Oct 2026 |
| 24 Aug 2026 | ANSHUL MAHESHWARI, Officer | 11,636 | $232.3K | 24 Aug 2026 |
| 24 Aug 2026 | DAVID & LAURA FRANCIS JOINT REV TRU/A DTD 01/03/2003, Director, Officer | 25,972 | $518.4K | 24 Aug 2026 |
| 21 Aug 2026 | DAVID & LAURA FRANCIS JOINT REV TRU/A DTD 01/03/2003, Director, Officer | 3,923 | $76.4K | 21 Aug 2026 |
| 21 Aug 2026 | ANSHUL MAHESHWARI, Officer | 11,228 | $218.7K | 21 Aug 2026 |
| 20 Aug 2026 | DAVID & LAURA FRANCIS JOINT REV TRU/A DTD 01/03/2003, Director, Officer | 51,884 | $1.0M | 20 Aug 2026 |
| 19 Aug 2026 | ANSHUL MAHESHWARI, Officer | 5,747 | $110.0K | 19 Aug 2026 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 14 Aug 2026 | Cadian Capital Management, LP | 13G | 7.5% | 3.3M |
| 30 Jul 2026 | BlackRock, Inc. | 13G amended | 8% | 3.6M |
| 7 May 2026 | First Light Asset Management, LLC | 13G amended | 18.36% | 8.1M |
| 24 Apr 2026 | BlackRock, Inc. | 13G amended | 6.9% | 3.1M |
| 27 Mar 2026 | The Vanguard Group | 13G amended | 0% | 0 |
| 17 Feb 2026 | OrbiMed Capital LLC | 13G amended | 0% | 0 |
| 13 Feb 2026 | BROWN ADVISORY INC | 13G amended | 5.79% | 2.5M |
| 13 Feb 2026 | American Century Mutual Funds, Inc. | 13G amended | 5.3% | 2.3M |
| 12 Feb 2026 | Champlain Investment Partners, LLC | 13G | 4.9% | 2.1M |
| 5 Dec 2025 | First Light Asset Management, LLC | 13G | 11.92% | 5.2M |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 4.7M | -8.05% | 8.67 |
| 30 Sep 2026 | 5.1M | -13.49% | 8.66 |
| 15 Sep 2026 | 5.9M | +5.1% | 10.65 |
| 31 Aug 2026 | 5.6M | +5.44% | 9.86 |
| 14 Aug 2026 | 5.3M | +5.04% | 10.91 |
| 31 Jul 2026 | 5.1M | -7.74% | 10.9 |
| 15 Jul 2026 | 5.5M | -7.88% | 8.93 |
| 30 Jun 2026 | 6.0M | +0.91% | 8.51 |
Funds that hold it
From each fund's latest Form 13F.
196 funds held it at 30 Jun 2026: 97 added and 46 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| First Light Asset Management, LLC | 8,127,985 | $132.6M | +2,774,795 |
| BlackRock, Inc. | 3,676,259 | $60.0M | +247,718 |
| Cadian Capital Management, LP | 3,347,574 | $54.6M | +1,460,102 |
| American Century Companies Inc. | 2,510,963 | $41.0M | +1,898 |
| Brown Advisory Inc. | 2,077,134 | $33.9M | -45,198 |
| Granahan Investment Management, LLC | 1,931,182 | $31.5M | +192,085 |
| Vanguard Capital Management LLC | 1,838,499 | $30.0M | +74,186 |
| First Eagle Investment Management, LLC | 1,537,882 | $25.1M | – |
| Impax Asset Management Group plc | 1,425,010 | $23.3M | 0 |
| Gilder Gagnon Howe & Co. LLC | 1,253,042 | $20.4M | +204,526 |
Peers
Companies in the same industry.
- Stryker Corp. (SYK): revenue $25.8B, market value $119.5B
- 3M Co. (MMM): revenue $25.2B, market value $91.6B
- Boston Scientific Corp. (BSX): revenue $21.0B, market value $61.9B
- Becton Dickinson & Co. (BDX): revenue $20.8B, market value $54.0B
- Resmed Inc. (RMD): revenue $5.7B, market value $35.5B
- Dexcom Inc. (DXCM): revenue $5.1B, market value $29.8B
- West Pharmaceutical Services Inc. (WST): revenue $3.4B, market value $29.1B
- Medline Inc. (MDLN): revenue –, market value $27.5B
- Glaukos Corp. (GKOS): revenue $690.3M, market value $14.3B
- Solventum Corp. (SOLV): revenue $8.3B, market value $14.2B